"Neurofibroma, Plexiform" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type of neurofibroma manifesting as a diffuse overgrowth of subcutaneous tissue, usually involving the face, scalp, neck, and chest but occasionally occurring in the abdomen or pelvis. The tumors tend to progress, and may extend along nerve roots to eventually involve the spinal roots and spinal cord. This process is almost always a manifestation of NEUROFIBROMATOSIS 1. (From Adams et al., Principles of Neurology, 6th ed, p1016; J Pediatr 1997 Nov;131(5):678-82)
| Descriptor ID |
D018318
|
| MeSH Number(s) |
C04.557.580.600.580.585 C10.551.775.500.750.500 C10.668.829.725.500.600.500
|
| Concept/Terms |
Neurofibroma, Plexiform- Neurofibroma, Plexiform
- Neurofibromas, Plexiform
- Plexiform Neurofibroma
- Plexiform Neurofibromas
- Tumor Royale
- Pachydermatocele
- Pachydermatoceles
- Elephantiasis Neuromatosis
- Elephantiasis Neuromatoses
- Neuromas, Plexiform
- Neuroma, Plexiform
- Plexiform Neuroma
- Plexiform Neuromas
|
Below are MeSH descriptors whose meaning is more general than "Neurofibroma, Plexiform".
Below are MeSH descriptors whose meaning is more specific than "Neurofibroma, Plexiform".
This graph shows the total number of publications written about "Neurofibroma, Plexiform" by people in this website by year, and whether "Neurofibroma, Plexiform" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neurofibroma, Plexiform" by people in Profiles.
-
Successful treatment of a child with MEK inhibitor-induced acneiform eruption with low-dose isotretinoin. Pediatr Dermatol. 2022 Jul; 39(4):646-647.
-
Clinical impact of selumetinib on pediatric elephantiasis neuromatosa. Pediatr Dermatol. 2022 Sep; 39(5):764-766.
-
Image segmentation of plexiform neurofibromas from a deep neural network using multiple b-value diffusion data. Sci Rep. 2020 10 20; 10(1):17857.
-
A molecular basis for neurofibroma-associated skeletal manifestations in NF1. Genet Med. 2020 11; 22(11):1786-1793.
-
Surgical Management of "Kissing" Spinal Plexiform Neurofibromas in Neurofibromatosis Type 1 Patients. World Neurosurg. 2020 Feb; 134:e1143-e1147.
-
Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype-phenotype correlation. Genet Med. 2019 04; 21(4):867-876.
-
Spinal and Paraspinal Plexiform Neurofibromas in Patients with Neurofibromatosis Type 1: A Novel Scoring System for Radiological-Clinical Correlation. AJNR Am J Neuroradiol. 2017 Oct; 38(10):1869-1875.
-
Unanticipated Compression of the Trachea in a 5-Month-Old Undergoing an MRI for Evaluation of Neurofibromatosis. A A Case Rep. 2017 Jan 01; 8(1):1-3.
-
Tumor burden evaluation in NF1 patients with plexiform neurofibromas in daily clinical practice. Acta Neurochir (Wien). 2015 May; 157(5):855-61.
-
Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas. Pediatr Blood Cancer. 2014 Sep; 61(9):1598-602.